Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective/Prospective, Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) With Clinical Significance.

NCT06213402 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT06213402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06213402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective/Prospective, Multicenter European Epidemiological Platform for Patients Diagnosed With Rare Anemia Disorders (RADs) With Clinical Significance.
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Observational
Overall status
Recruiting
Start date
November 30, 2021
Completion date
November 30, 2036
Enrollment
32,564 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia due to membrane defect, cda, constitutional aplastic anemia, hemolytic; anemia, hereditary, due to enzyme disorder, hereditary anemia, iron metabolism disorders, sickle cell disease, sideroblastic anemia, thalassemia